Prot# 100013: A 12 Week, Double-Blind, Placebo Controlled, Twice Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Project: Research project

Project Details

StatusFinished
Effective start/end date11/15/04 → 5/24/06

Funding

  • GlaxoSmithKline plc (100013)